Cargando…
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
Evidence regarding effectiveness and safety of clozapine once- vs. multiple-daily dosing is limited. We compared demographic and clinical parameters between patients with once- vs. multiple-daily dosing in the Department of Psychiatry and Psychotherapy, University of Regensburg, Germany (AGATE datas...
Autores principales: | Kuzo, Nazar, Haen, Ekkehard, Ho, Dominic M., Takeuchi, Hiroyoshi, Piras, Marianna, Eap, Chin-Bin, de Filippis, Renato, Homan, Philipp, Kane, John M., Roy, Marc-André, Paulzen, Michael, Schoretsanitis, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465369/ https://www.ncbi.nlm.nih.gov/pubmed/36580106 http://dx.doi.org/10.1007/s00406-022-01542-1 |
Ejemplares similares
-
Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia
por: Gaebler, Arnim Johannes, et al.
Publicado: (2023) -
Plasma Risperidone-related Measures in Children and Adolescents with Oppositional Defiant/Conduct Disorders
por: Piacentino, Daria, et al.
Publicado: (2020) -
PS212. Effects of Proton Pump Inhibitors (PPI) on the Serum Concentrations of Venlafaxine
por: Paulzen, Michael, et al.
Publicado: (2016) -
Co-occurrence of clozapine-related DRESS syndrome core clinical manifestations: results of a systematic review
por: De Filippis, R., et al.
Publicado: (2022) -
Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile
por: de Filippis, Renato, et al.
Publicado: (2021)